Pan-Cancer Computational Analysis of RKIP (

Evangelia Skouradaki, Apostolos Zaravinos, Maria Panagopoulou, Ekaterini Chatzaki, Nikolas Dovrolis, Stavroula Baritaki

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

COL5A1 in the tumor microenvironment predicts the prognosis of head and neck cancer.Science progress
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Evangelia SkouradakiLaboratory of Experimental Oncology, Division of Surgery, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Apostolos ZaravinosCancer Genetics, Genomic and Systems Biology Group, Basic and Translational Cancer Research Center (BTCRC), 1516 Nicosia, Cyprus.ORCID 0000-0003-4625-5562

Maria PanagopoulouLaboratory of Pharmacology, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-7107-4774

Ekaterini ChatzakiLaboratory of Pharmacology, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-5832-4257

Nikolas DovrolisLaboratory of Pharmacology, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-3832-9939

Stavroula BaritakiLaboratory of Experimental Oncology, Division of Surgery, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RKIP and LKB1, encoded by

Indexed as

NeoplasmsPhosphatidylethanolamine Binding ProteinProtein Serine-Threonine KinasesTumor MicroenvironmentAMP-Activated Protein Kinase KinasesBiomarkers, TumorComputational BiologyGene Expression Regulation, NeoplasticHumansPrognosisTranscriptomeAMP-Activated Protein Kinase KinasesBiomarkers, TumorPEBP1 protein, humanPhosphatidylethanolamine Binding ProteinProtein Serine-Threonine KinasesSTK11 protein, humancancerLKB1RKIPtumor microenvironment

Identifiers

PMID40806276

DOI10.3390/ijms26157145

PMCPMC12346703

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.